Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New KDM1A inhibitors synthesized at Hanmi Science

Aug. 24, 2020

Femtogenix discloses G-A crosslinking cytotoxic agents

Aug. 24, 2020

Velexbru granted supplemental approval in Japan

Aug. 24, 2020

New CDK2/cyclin E inhibitors discovered at Pfizer

Aug. 24, 2020

NSC-801845, a novel cytidine analogue with excellent activity in number of tumor models

Aug. 24, 2020

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent ADORA2A/B antagonists

Aug. 21, 2020

Phosphodiesterase PDE3A and PDE3B inhibitors described by Bayer, The Broad Institute

Aug. 21, 2020

ORIC Pharmaceuticals' OP-4954 displays selective glucocorticoid receptor antagonism

Aug. 21, 2020

Early interim data and regulatory update for phase II TRIDENT-1 study of repotrectinib

Aug. 20, 2020

Betta Pharmaceuticals identifies new SHP-2 inhibitors

Aug. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...